Thursday, April 20, 2017 8:31:23 PM
They range from
1. Fast Track - requiring additional testing before they make a determination. May or may not include Rolling Approvals and/or Priority Review
2. Rolling Approvals - meaning they approve portions of the BLA as they get the information in,
3. Priority Review - which would involve assigning an FDA agent to meet with the company on regular intervals to help them along with the process of approval.
4. Conditional Approval - they are also calling this Phase 4. It gives the company the ability to market the product immediately. The company must report safety and efficacy of their drug or device as results come in. Generally the company will be required to report results for 6 months.
Fact Track would be very good, but Conditional Approval immediately makes the company golden.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM